← back to search
Wei Jiang
Fudan University
· CN
Area of research
Cell Biology · Cancer Research
Research interest
Research interests include Cancer research, Medicine, Hydroxylation, Lymphoma, Chemistry, and Kinase.
h-index
—
citations
84
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression
Journal of Clinical Investigation
2023
cited by
41
position: middle
doi
Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin
Blood
2018
cited by
43
position: first
doi
Grants
No grants ingested yet.
Frequent collaborators
Yongjun Dang
· Fudan University
2
papers (2018–2023)
Zengxia Li
· Fudan University
2
papers (2018–2023)
Weige Wang
· Apocare Pharma (Germany)
1
papers (2018–2018)
Zhaomeng Cui
· The First Affiliated Hospital, Sun Yat-sen University
1
papers (2018–2018)
Qian Yu
· Fudan University
1
papers (2023–2023)
Joong Sup Shim
· Center for Cancer Research
1
papers (2023–2023)
Jun O. Liu
· Central China Normal University
1
papers (2018–2018)
K. Dengke
· University of California, San Francisco
1
papers (2018–2018)
Ruina Wang
· Fudan University
1
papers (2023–2023)
Lizhi Jiang
· Guilin University of Electronic Technology
1
papers (2018–2018)
Quanfu Li
· Fudan University
1
papers (2018–2018)
Jing Huang
· Wenzhou Medical University
1
papers (2023–2023)
—
·
1
papers (2018–2018)
Renke Tan
· Shanghai Medical College of Fudan University
1
papers (2018–2018)
Suqin Shen
· University of Miami
1
papers (2018–2018)
Jun Hou
· Shihezi University
1
papers (2023–2023)
Zewen Zhu
· Fudan University
1
papers (2023–2023)
Meirong Bai
· Shanghai Jiao Tong University
1
papers (2018–2018)
Minjia Tan
· Eighth Affiliated Hospital of Sun Yat-sen University
1
papers (2018–2018)
Jiaoyu Shan
· Xinjiang Medical University
1
papers (2018–2018)